Primary analysis of Zuma-7: A phase 3 randomized trial of axicabtagene ciloleucel (axi-cel) versus standard-of-care (SOC) therapy in patients with relapsed/refractory large B-cell lymphoma Meeting Abstract
| Authors: | Locke, F. L.; Miklos, D. B.; Jacobson, C. A.; Perales, M. A.; Kersten, M. J.; Oluwole, O. O.; Ghobadi, A.; Rapoport, A. P.; McGuirk, J. P.; Pagel, J. M.; Muñoz, J.; Farooq, U.; van Meerten, T.; Reagan, P. M.; Sureda, A.; Flinn, I. W.; Vandenberghe, P.; Song, K. W.; Dickinson, M.; Minnema, M. C.; Riedell, P. A.; Leslie, L. A.; Chaganti, S.; Yang, Y.; Filosto, S.; Schupp, M.; To, C.; Cheng, P.; Gordon, L. I.; Westin, J. R. |
| Abstract Title: | Primary analysis of Zuma-7: A phase 3 randomized trial of axicabtagene ciloleucel (axi-cel) versus standard-of-care (SOC) therapy in patients with relapsed/refractory large B-cell lymphoma |
| Meeting Title: | 2022 Tandem Meetings of ASTCT and CIBMTR |
| Journal Title: | Transplantation and Cellular Therapy |
| Volume: | 28 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2022 Apr 23-26 |
| Meeting Location: | Salt Lake City, UT |
| ISSN: | 2666-6375 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-03-01 |
| Start Page: | S1 |
| Language: | English |
| ACCESSION: | WOS:000779042400001 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2666-6367(22)00162-2 |
| Notes: | Meeting Abstract: 1 -- Located within the section named "Tandem Meeting Best Abstracts" -- Source: Wos |
